Specialty: Internal Medicine
Sub-specialty: Nephrology

Bill Clark is a Professor of Medicine at Western University Canada,  a Scientist at the Lawson Health Research Institute, a Director of Apheresis and Consulting Nephrologist at the London Health Sciences Centre. Dr. Clark is a graduate of Western University Canada and obtained his fellowship training in Internal Medicine and Nephrology at the University of Toronto, Western University Canada, Guys and Kings College Hospital UK. He obtained post fellowship training at the University of London and London School of Economics UK and Faculty of Epidemiology at McGill University. Dr. Clark is a clinician scientist in the Program of Experimental Medicine whose research has been directed at interventions that prevent progressive renal disease and are based on in vitro and in vivo animal and human experimentation as well as observational studies and randomized controlled trials. He is author of more than 390 scholarly publications, a Professor of Medicine and former Chairman of the Division of Nephrology at Western University Canada who also serves on the Boards of the World Apheresis Association (President 2016-18) and the Canadian Apheresis Group and was Scientific Co-Chair, Biomedical Research Council of the Kidney Foundation of Canada (2014-2018), Chair Review Committee Can SOLVE (2018-2019) and a member of the Canadian Society of Nephrology Scientific Committee. Dr. Clark is the 2012 recipient of the National Medal of Research Excellence of the Kidney Foundation of Canada and the Queen Elizabeth II Diamond Jubilee Medal and a recently elected Fellow of the Canadian Academy of Health Sciences and in 2014 he was the honoured recipient of the Harold W. Ashenmil National Award from the Kidney Foundation of Canada in recognition of his leadership and development. In 2015 he received the Lawson Health Research Institute Career Scientist Award and in 2018 The Dosseter Award for Administrative Research Excellence.

Areas of Expertise: Epidemiology, thrombotic microangiopathies, aphaeresis,observational studies, Randomized Controlled Clinical Trials, Cost Benefit Analysis, Interventions/ Renal Disease, autoimmune diseases, Lupus Nephritis, Systemic Vasculitis.

Dr. Vrielink (1958) was educated at the University of Amsterdam in Medicine and wrote his thesis (1996) on the ‘Laboratory diagnosis of viruses transmitted by blood transfusion’. He works since 1985 as transfusion and apheresis medicine specialist at Sanquin Blood Supply Foundation, the national blood transfusion service in the Netherlands. He has published many articles and chapters in internationally recognized journals and books on various subjects. Hans Vrielink is initiator of (inter)national courses in the field of apheresis for physicians and nurses and trained since 2013 almost 1,000 apheresis nurses and physicians.

Presently, Hans Vrielink serves as portfolio manager of the Apheresis Department of the Unit of Transfusion Medicine for Sanquin Blood Supply and as senior consultant of the department of Sanquin Consulting Services. In this part of the job, he is involved in training and advising organisations and governments in low and middle income countries in blood banking, transfusion medicine and apheresis all over the world.

Besides his work at Sanquin Blood Supply, Hans Vrielink is collection facility director of number of hospitals in the Netherlands. He is international JACIE / FACT inspector. Hans Vrielink is involved in many international associations, for instance as past-president of the European Society for Hemapheresis, and incoming president of the World Apheresis Association.

Dr. Weinstein is a Phi Beta Kappa, Magna Cum Laude graduate of Brandeis University, Waltham, Massachusetts, where he majored in chemistry.  After graduating from the New York University School of Medicine in New York City, he completed an internship and residency in Internal Medicine at the University of Miami Affiliated Hospitals program in Miami, Florida.  He returned to New England as a fellow in hematology at the Beth Israel Hospital, Boston, where he stayed after completing his fellowship, and ultimately gained an appointment as Assistant Professor of Medicine at Harvard Medical School.  In 1985 he joined the Division of Hematology/Oncology at St. Elizabeth’s Medical Center of Boston, a Tufts Medical School affiliate, where he established a program in therapeutic and donor apheresis. He later directed the Hematology and Transfusion Medicine section of the Division and became Professor of Medicine at Tufts.  In 2006 he became the founding Chief of the Division of Transfusion Medicine at the UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts, where he served as Professor of Medicine, Pathology and Nursing and, among other duties, co-Director of the “Host Defense and Blood” course in the first-year medical school curriculum, until November 2019.  He is now Professor Emeritus in the Department of Medicine.

Dr. Weinstein has served as chair of the Hemapheresis Committee of AABB and chair of the Committee on Practice of the American Society of Hematology.  He is past-president of the American Society for Apheresis, and of the World Apheresis Association.  He served as Editor-in-Chief of the Journal of Clinical Apheresis from 2004 to 2015.  He currently serves on the Board of Directors of the World Apheresis Association as Vice President for the Americas.

Miquel Lozano, MD, PhD is hematologist. Currently he is Hemotherapy Section Head at the department of Hemotherapy and Hemostasis of the Clínic University Hospital, and Associate Professor of Medicine at the University of Barcelona, in Barcelona, Spain. He is currently president of the European Society for Hemapheresis and member of the World Apheresis Association Executive Board

In the past he has been the European Regional Director of the ISBT Board between 2014 and 2018 and chair of the AABB Press Editorial Board between 2008 and 2018. He has been scientific member of BEST Collaborative between 2002 and 2018 and currently is an honorary member of BEST.

He is currently associate editor of Transfusion journal and member of the editorial board of Vox Sanguinis, Transfusion Medicine Reviews, Transfusion and Apheresis Science.

He is the author or co-author of over 230 papers, monographs and book chapters dealing with topics related with Transfusion Medicine and Hemostasis. He has co-edited books for AABB Press about Globalization in Transfusion Medicine, Blood Component Preparation and Platelet Transfusion Therapy. He is a frequent speaker in national and international meetings where he has delivered more than 120 presentations.

Dr. Ma. Angelina Mirasol is a Clinical Associate Professor at the University of the Philippines- Philippine General Hospital (UP-PGH) and the University of the Philippines- College of Medicine (UPCM). She is an actively practicing Adult Hematologist of the Section of Hematology under the Department of Medicine, former Assistant Head/OIC of the Section of Blood Bank, Apheresis and Transfusion Medicine of the Department of Laboratory and chair of the Hospital Blood Transfusion Committee of the same Institution. She has served as assistant director for Chemotherapy and Research, and assistant director for training of the Cancer Institute of UP-PGH. She heads the Section of Hematology of the Department of Medicine of Our Lady of Lourdes Hospital.

She has chaired and held positions in several task forces on Anemia/ Aplastic Anemia- PNH, Hematologic Malignancies, Thrombosis and Hemostasis, Hemophilia, and Transfusion Medicine under the Philippine Society of Hematology and Blood Transfusion (PSHBT), DOH, and other Organizations, including the Thalassemia International Federation, World Federation of Hemophilia, co chaired in the Asia Pacific Scientific Fora on Thrombosis and Hemostasis held in the Philippines in collaboration with the Asia Pacific  International Society of Thrombosis and Hemostasis/Internationa Society of Thrombosis and Hemostasis, and among the Council of Advisers of the Asean Federation of Hematology; the Department of Health of the Philippines, where she was a consultant of the National Voluntary Blood Services Program. She is a past President of PSHBT, currently Secretary of the Philippine College of Hematology and Transfusion Medicine, and Vice President for Asia Pacific of the World Association for Apheresis.

She has authored, co authored several scientific papers and chapters/ sections in books presented and published locally and internationally, tackling on: Anemia, Management of Hematologic Complications during endoscopy (book), Technical Manual on Transfusion Medicine and Practice Guidelines in Blood Transfusion in the Philippines, Survival patterns in Acute Myelogenous Leukemia, Thalassemia and Hemoglobinopathy Screening among blood donors, National Survey on Blood Safety, and other topics.

She is a reviewer of the Journal ACTA Medica of the UPCM, and has reviewed research papers both locally and internationally for hematologic and transfusion topics as well as for the previous HIV International Congresses (Indonesia and Korea).

Currently, she has ongoing projects on several hematologic disorders and procedures including Thalassemia and Hemoglobinopathies in the Philippines, Sociodemographic Impacts of HIV Seropositive Blood Donors, Apheresis experience on different diseases, Registry on lymphoma and myeloma (with PSHBT) as well as collaborative studies with institutions and organizations.

Joseph (Yossi) Schwartz MD, MPH is a Professor of Pathology and Cell Biology at the College of Physician and Surgeons of Columbia University and the Director of the Transfusion Medicine & Cellular Therapy Service at the Columbia University Medical Center campus of the New York Presbyterian Hospital. As the Director of the Transfusion Medicine & Cellular Therapy Service, Dr. Schwartz oversees the Blood Bank, The Apheresis unit and the Cell Therapy facility. As a major tertiary & transplantation center, those facilities collect, receive & process blood products for transfusion in variety of indications such as patients with Sickle Cell Disease, complex cardiac surgery, Hematopoietic Progenitor Cell transplantation, and all types of solid organ transplantation. He was until recently the chair of the FACT-JACIE international standards for cellular therapy and he is currently the President of the American Society for Apheresis (ASFA).

DRK Blutspendedienst Cottbus
Porträts Prof. Dr. Rainer Moog und Undine Schulz

1979 – 1986 medical studies at University of Essen, Germany
1986 –  full medical registration
1987 – doctoral thesis
1987 – residency at the Institute for Transfusion Medicine, University Clinics Essen, Germany
1996 – board certification in Transfusion Medicine
1996 – guest physician at the Immunhematology Service of the San Martino Hospital in Genoa, Italy
1999-2008  – member of the ethics committee of the Chamber of Physicians Northrhine
2000 –  master thesis for Transfusion Medicine
2002 – 2006 – head of Research and Development at the German Red Cross Blood Donor Service West “Karl-Landsteiner” Foundation
2006 – Associate Professor
2007 – board certification in Hemostaseology
2006 – 2008 – interim director of the Institute for Transfusion Medicine at the University Clinics Essen, Germany
2008 – 2009 – head of Munich Blood Bank, Germany
2010 – 2013 – head of Transfusion Service plusBlut, Brandenburg, Germany
2013-2018 – medical director German Red Cross Blood Donor Service North East, Institute Cottbus, Germany
since 2019 – regional medical head Octapharma Plasma

Scientific society memberships
German Society for Transfusion Medicine and Immunhematology (DGTI)
German Society for Clinical Chemistry and Laboratory Medicine (DGKL)
Society for Thrombosis and Hemostasis (GTH)
European Society for Haemapheresis and Haemotherapy (ESFH)
European Federation of Immunogenetics (EFI)
Network for Patient Blood Management, Thrombosis and Hemostasis and (NATA)
International Society of Blood Transfusion (ISBT)
American Association of Blood Banks (AABB)

Current Editorial board memberships
Transfusion Medicine and Hematotherapy
Transfusion and Apheresis Science

Publications
Original papers: 50
Reviews: 13
Book contributions: 11
Letters: 11
Abstracts: 168
Miscellaneous: 26
Presentations: 257

Languages
German (native), English (fluent), French, Italian, Turkish (basics)

Soon

Tim Brown is Global Director of Therapeutics Marketing at Terumo BCT. A pharmacologist by training, he has previously held roles at multiple pharmaceutical and biotechnology companies